Que sera, sera: Evolution of the swine H1N1 influenza A virus

Expert Review of Anti-Infective Therapy

Volumn 7, Issue 7, 2009, Pages 763-768

  Hensley, Scott E ^a   Yewdell, Jonathan W ^a  

^a NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

INFLUENZA VACCINE; INFLUENZA VIRUS HEMAGGLUTININ; OSELTAMIVIR; VIRUS PROTEIN; ZANAMIVIR;

ANTIGENICITY; EDITORIAL; EPITOPE MAPPING; GENE MUTATION; HUMAN; IMMUNE RESPONSE; INFLUENZA; INFLUENZA VIRUS A H1N1; MOLECULAR EVOLUTION; NONHUMAN; PANDEMIC; PROTEIN ANALYSIS; SWINE INFLUENZA VIRUS; VACCINATION; VIRAL GENETICS; VIRUS IDENTIFICATION; VIRUS REPLICATION; VIRUS STRAIN; VIRUS TRANSMISSION;

ANIMALS; ANTIGENS, VIRAL; EVOLUTION, MOLECULAR; GENOTYPE; HEMAGGLUTININ GLYCOPROTEINS, INFLUENZA VIRUS; HUMANS; INFLUENZA A VIRUS, H1N1 SUBTYPE; INFLUENZA, HUMAN; MODELS, MOLECULAR; MUTATION; ORTHOMYXOVIRIDAE INFECTIONS; SWINE;

EID: 70350630446     PISSN: 14787210     EISSN: 17448336     Source Type: Journal    
DOI: 10.1586/ERI.09.62     Document Type: Editorial

References (44)

1. Swine influenza A (H1N1) infection in two children - southern California, March-April 2009. MMWR 58(15), 400-402 (2009).
2. Clark T, Stephenson I. Influenza A/H1N1 in 2009: a pandemic in evolution. Expert Rev. Vaccines 8(7), 819-822 (2009).
3. Conenello GM, Palese P. Influenza A virus PB1-F2: a small protein with a big punch. Cell Host Microbe 2(4), 207-209 (2007). (Pubitemid 47500827)
4. Wise HM, Foeglein A, Sun J et al. A complicated message: identification of a novel PB1-related protein translated from influenza A segment 2 mRNA. J. Virol. 83(16), 8021-8031 (2009).
5. Zhirnov OP, Poyarkov SV, Vorob'eva IV, Safonova OA, Malyshev NA, Klenk HD. Segment NS of influenza A virus contains an additional gene NSP in positive-sense orientation. Dokl. Biochem. Biophys. 414(1), 127-133 (2007).
6. Garten RJ, Davis CT, Russell CA et al. Antigenic and genetic characteristics of swine-origin 2009 A(H1N1) influenza viruses circulating in humans. Science 325(5937), 197-201 (2009).
7. Smith GJ, Vijaykrishna D, Bahl J et al. Origins and evolutionary genomics of the 2009 swine-origin H1N1 influenza A epidemic. Nature 459(7250), 1122-1125 (2009).
8. Dawood FS, Jain S, Finelli L et al. Emergence of a novel swine-origin influenza A (H1N1) virus in humans. N. Engl. J. Med. 360(25), 2605-2615 (2009).
9. Myers KP, Olsen CW, Gray GC. Cases of swine influenza in humans: a review of the literature. Clin. Infect. Dis. 44(8), 1084-1088 (2007).
10. Fraser C, Donnelly CA, Cauchemez S et al. Pandemic potential of a strain of influenza A (H1N1): early findings. Science 324(5934), 1557-1561 (2009).
11. Stambas J, Guillonneau C, Kedzierska K, Mintern JD, Doherty PC, La Gruta NL. Killer T cells in influenza. Pharmacol. Ther. 120(2), 186-196 (2008).
12. Seo SH, Webster RG. Cross-reactive, cell-mediated immunity and protection of chickens from lethal H5N1 influenza virus infection in Hong Kong poultry markets. J. Virol. 75(6), 2516-2525 (2001).
13. Yewdell JW, Frank E, Gerhard W. Expression of inf luenza A virus internal antigens on the surface of infected P815 cells. J. Immunol. 126, 1814-1819 (1981).
14. Staerz UD, Yewdell JW, Bevan MJ. Hybrid antibody-mediated lysis of virus-infected cells. Eur. J. Immunol. 17(4), 571-574 (1987).
15. Gerhard W, Mozdzanowska K, Zharikova D. Prospects for universal influenza virus vaccine. Emerg. Infect. Dis. 12(4), 569-574 (2006).
16. Knossow M, Skehel JJ. Variation and infectivity neutralization in influenza. Immunology 119(1), 1-7 (2006).
17. Ekiert DC, Bhabha G, Elsliger MA et al. Antibody recognition of a highly conserved influenza virus epitope. Science 324(5924), 246-251 (2009).
18. Sui J, Hwang WC, Perez S et al. Structural and functional bases for broad-spectrum neutralization of avian and human influenza A viruses. Nat. Struct. Mol. Biol. 16(3), 265-273 (2009).
19. Yewdell JW, Gerhard W. Antigenic characterization of viruses by monoclonal antibodies. Annu. Rev. Microbiol. 35, 185-206 (1981).
20. Gerhard W, Webster RG. Antigenic drift in influenza A viruses. I. Selection and characterization of antigenic variants of A/PR/8/34 (HON1) influenza virus with monoclonal antibodies. J. Exp. Med. 148, 383-392 (1978). (Pubitemid 8392703)
21. Gerhard W, Yewdell J, Frankel ME, Webster R. Antigenic structure of influenza virus haemagglutinin defined by hybridoma antibodies. Nature 290(5808), 713-717 (1981). (Pubitemid 11068963)
22. Caton AJ, Brownlee GG, Yewdell JW, Gerhard W. The antigenic structure of the influenza virus A/PR/8/34 hemagglutinin (H1 subtype). Cell 31(2 Pt 1), 417-427 (1982). (Pubitemid 13178866)
23. Green N, Alexander H, Olson A et al. Immunogenic structure of the influenza-virus hemagglutinin. Cell 28(3), 477-487 (1982).
24. Muller GM, Shapira M, Arnon R. Anti-influenza response achieved by immunization with a synthetic conjugate. Proc. Natl Acad. Sci. USA 79(2), 569-573 (1982).
25. Staudt LM, Gerhard W. Generation of antibody diversity in the immune response of BALB/c mice to influenza virus hemagglutinin. I. Significant variation in repertoire expression between individual mice. J. Exp. Med. 157(2), 687-704 (1983). (Pubitemid 13145069)
26. Yewdell JW, Webster RG, Gerhard WU. Antigenic variation in three distinct determinants of an influenza type A haemagglutinin molecule. Nature 279(5710), 246-248 (1979).
27. Wilson IA, Cox NJ. Structural basis of immune recognition of influenza virus hemagglutinin. Ann. Rev. Immunol. 8, 737-771 (1990).
28. Wang ML, Skehel JJ, Wiley DC. Comparative analyses of the specificities of anti-influenza hemagglutinin antibodies in human sera. J. Virol. 57(1), 124-128 (1986).
29. Yewdell JW, Caton AJ, Gerhard W. Selection of influenza A virus adsorptive mutants by growth in the presence of a mixture of monoclonal antihemagglutinin antibodies. J. Virol. 57(2), 623-628 (1986). (Pubitemid 16147868)
30. Fazekasd S. Evolution and hierarchy of influenza viruses. Arch. Environ. Health 21(3), 293-303 (1970).
31. Smith DJ, Lapedes AS, de Jong JC et al. Mapping the antigenic and genetic evolution of influenza virus. Science 305(5682), 371-376 (2004).
32. Nelson MI, Simonsen L, Viboud C et al. Stochastic processes are key determinants of short-term evolution in influenza a virus. PLoS Pathog. 2(12), e125 (2006).
33. Soundararajan V, Tharakaraman K, Raman R et al. Extrapolating from sequence - the 2009 H1N1 'swine' influenza virus. Nat. Biotechnol. 27(6), 510-513 (2009).
34. Kilbourne ED, Smith C, Brett I, Pokorny BA, Johansson B, Cox N. The total influenza vaccine failure of 1947 revisited: major intrasubtypic antigenic change can explain failure of vaccine in a post-World War II epidemic. Proc. Natl Acad. Sci. USA 99(16), 10748-10752 (2002).
35. Yu X, Tsibane T, McGraw PA et al. Neutralizing antibodies derived from the B cells of 1918 influenza pandemic survivors. Nature 455(7212), 532-536 (2008).
36. Raymond FL, Caton AJ, Cox NJ, Kendal AP, Brownlee GG. The antigenicity and evolution of influenza H1 haemagglutinin, from 1950-1957 and 1977-1983: two pathways from one gene. Virology 148(2), 275-287 (1986).
37. Russell CA, Jones TC, Barr IG et al. The global circulation of seasonal influenza A (H3N2) viruses. Science 320(5874), 340-346 (2008).
38. Van Hoeven N, Pappas C, Belser JA et al. Human HA and polymerase subunit PB2 proteins confer transmission of an avian influenza virus through the air. Proc. Natl Acad. Sci. USA 106(9), 3366-3371 (2009).
39. Conenello GM, Zamarin D, Perrone LA, Tumpey T, Palese P. A single mutation in the PB1-F2 of H5N1 (HK/97) and 1918 influenza A viruses contributes to increased virulence. PLoS Pathog. 3(10), 1414-1421 (2007). (Pubitemid 350085606)
40. Zamarin D, Ortigoza MB, Palese P. Influenza A virus PB1-F2 protein contributes to viral pathogenesis in mice. J. Virol. 80(16), 7976-7983 (2006). (Pubitemid 44182298)
41. Steel J, Lowen AC, Mubareka S, Palese P. Transmission of influenza virus in a mammalian host is increased by PB2 amino acids 627K or 627E/701N. PLoS Pathog. 5(1), e1000252 (2009).
42. Global Initiative on Sharing Avian Influenza Data http://platform.gisaid. org
43. National Center for Biotechnology Information www.ncbi.nlm.nih.gov/ genomes/FLU/SwineFlu.html
44. The Swine Flu Affair www.iom.edu/cms/aboutiOM/4081/65926.aspx